Clarifying these central mechanisms is crucial, as the brain plays a vital role in regulating energy balance, and understanding how GIP affects central pathways to modulate food intake will be invaluable for improving GIP-based therapies for obesity and diabetes treatment. The gene discussed is GIP; the disease is obesity due to melanocortin 4 receptor deficiency.